Our laboratory is working with both academic researchers and commercial companies to support ongoing research into biomarkers associated with various neurologic diseases and neurotrauma. Much of our contract work involves studies to confirm the detection of specific biomarkers of interest, and to design protocols for diagnostic or monitoring applications. Working within a CLIA laboratory environment, we can provide a blood-based assay that is repeatable, cost effective and fits easily into a routine diagnostic or research environment.

Our proprietary exosome isolation technology is covered by a recently granted patent, with 5 additional patent applications in process to cover various aspects of BDE processing and marker application. Using BDEs to explore clinical applications in neurodegenerative diseases is supported by several peer-reviewed publications. We are ready to work with you to help move your important biomarker projects forward.